Objective: To examine morphologic changes in the meibomian glands associated with patients with Graves' orbitopathy (GO) using a novel meibography imaging system, and to evaluate its correlation with GO clinical manifestations.
Design: Retrospective, observational case series.
Participants: Fifty-one GO patients and 31 normal control participants.